Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Laryngeal Neoplasms × Electroporation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 13 Prostatic Neoplasms 8 Carcinoma, Hepatocellular 7 Liver Neoplasms 5 Neoplasm Metastasis 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Unresectable Pancreatic Cancer 2 Stomach Neoplasms 2 Squamous Intraepithelial Lesions 2 Neoplasms 2 Melanoma 2 Lymphatic Metastasis 2 Locally Advanced Pancreatic Cancer 2 Cholangiocarcinoma 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Adenocarcinoma Resectable 1 Liver, Cancer of, Non-Resectable 1 Liver Metastasis Colon Cancer 1

Interventions

Cisplatin 28 Magnetic Resonance Spectroscopy 17 Radiotherapy 16 Cetuximab 16 Specimen Handling 14 pembrolizumab 12 Carboplatin 11 Radiotherapy, Intensity-Modulated 10 Fluorouracil 10 Docetaxel 9 Platinum 8 1,2-diaminocyclohexaneplatinum II citrate 8 Surgical Procedures, Operative 7 Radiation 7 Paclitaxel 7 Biopsy 6 Drug Therapy 5 toripalimab 4 Taxes 4 Standard of Care 4 (225)Ac-DOTA-c(RGDyK) 4 X-Rays 3 Nutritional Status 3 Laser Therapy 3 Fluorodeoxyglucose F18 3 Celecoxib 3 130-nm albumin-bound paclitaxel 3 motexafin gadolinium 2 ipatasertib 2 durvalumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02430675 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡